The Valley Desk

NCT00171210 · Interventional trial

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Overall registry status Completed

Phase 3

Conditions Transfusional Iron Overload in β-thalassemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov